載入...
Phosphoinositide 3‐kinase δ is a regulatory T‐cell target in cancer immunotherapy
Tumour infiltration by regulatory T (Treg) cells contributes to suppression of the anti‐tumour immune response, which limits the efficacy of immune‐mediated cancer therapies. The phosphoinositide 3‐kinase (PI3K) pathway has key roles in mediating the function of many immune cell subsets, including T...
Na minha lista:
| 發表在: | Immunology |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587315/ https://ncbi.nlm.nih.gov/pubmed/31107985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.13082 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|